Home
BRNS
BRNS News

Latest Barinthus Biotherapeutics plc (BRNS) News on November 17, 2024

Barinthus Bio Announces Results From Ongoing Phase 2b Chronic Hepatitis B Trial, Including Achievement of Functional Cure and HBsAb Seroconversion

GlobeNewswire

2 days ago

Barinthus Bio Announces Results From Ongoing Phase 2b Chronic Hepatitis B Trial, Including Achievement of Functional Cure and HBsAb Seroconversion

Arbutus and Barinthus Bio Announce New Data from the IM-PROVE II Trial Showing that the Addition of Nivolumab Increased Rates of HBsAg Loss in People with Chronic Hepatitis B

GlobeNewswire

2 days ago

Arbutus and Barinthus Bio Announce New Data from the IM-PROVE II Trial Showing that the Addition of Nivolumab Increased Rates of HBsAg Loss in People with Chronic Hepatitis B

Barinthus Bio Reports Third Quarter 2024 Update on Corporate Developments and Financial Results

GlobeNewswire

11 days ago

Barinthus Bio Reports Third Quarter 2024 Update on Corporate Developments and Financial Results

Barinthus Bio Announces Late Breaking Presentation at AASLD 2024 – The Liver Meeting® and Attendance at November Conferences

GlobeNewswire

17 days ago

Barinthus Bio Announces Late Breaking Presentation at AASLD 2024 – The Liver Meeting® and Attendance at November Conferences

ChromaDex Leads The Charge With 2 Other US Penny Stocks To Watch

Simply Wall St.

25 days ago

ChromaDex Leads The Charge With 2 Other US Penny Stocks To Watch

Barinthus Bio Completes Enrollment for Phase 2b HBV003 Clinical Trial in Chronic Hepatitis B and Phase 1 PCA001 Clinical Trial in Prostate Cancer

GlobeNewswire

2 months ago

Barinthus Bio Completes Enrollment for Phase 2b HBV003 Clinical Trial in Chronic Hepatitis B and Phase 1 PCA001 Clinical Trial in Prostate Cancer

Barinthus Bio Initiates Phase 1 Clinical Trial of VTP-1000 for the Treatment of Celiac Disease

GlobeNewswire

2 months ago

Barinthus Bio Initiates Phase 1 Clinical Trial of VTP-1000 for the Treatment of Celiac Disease

Barinthus Bio Reports Second Quarter 2024 Update on Corporate Developments and Financial Results

GlobeNewswire

3 months ago

Barinthus Bio Reports Second Quarter 2024 Update on Corporate Developments and Financial Results

Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors

GlobeNewswire

4 months ago

Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors

Here's Why We're Watching Barinthus Biotherapeutics' (NASDAQ:BRNS) Cash Burn Situation

Simply Wall St.

4 months ago

Here's Why We're Watching Barinthus Biotherapeutics' (NASDAQ:BRNS) Cash Burn Situation

Barinthus Bio Announces Strategic Pipeline Prioritization Following Positive Interim Data from VTP-300 in Chronic Hepatitis B Virus Infections

GlobeNewswire

5 months ago

Barinthus Bio Announces Strategic Pipeline Prioritization Following Positive Interim Data from VTP-300 in Chronic Hepatitis B Virus Infections

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

GOBankingRates

5 months ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller

AFP

5 months ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up

AFP

5 months ago

Italy beat Bosnia in final Euros warm-up

Macron Calls French Legislative Election After Far-Right Surge

Bloomberg

5 months ago

Macron Calls French Legislative Election After Far-Right Surge

Trump loyalists proud to support 'felon' at Las Vegas rally

AFP

5 months ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

Business Insider

5 months ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women

Insider Monkey

5 months ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Reuters

5 months ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Barinthus Bio's VTP-300 Trials Demonstrate Ability to Achieve Undetectable HBsAg levels and Statistical Significance in Lowering HBsAg Levels in People with Chronic Hepatitis B

GlobeNewswire

5 months ago

Barinthus Bio's VTP-300 Trials Demonstrate Ability to Achieve Undetectable HBsAg levels and Statistical Significance in Lowering HBsAg Levels in People with Chronic Hepatitis B

Barinthus Bio to Present VTP-300 Clinical Data Updates at EASL Congress 2024

GlobeNewswire

6 months ago

Barinthus Bio to Present VTP-300 Clinical Data Updates at EASL Congress 2024

Barinthus Bio Reports First Quarter 2024 Financial Results and Update on Corporate Developments

GlobeNewswire

6 months ago

Barinthus Bio Reports First Quarter 2024 Financial Results and Update on Corporate Developments

Increases to CEO Compensation Might Be Put On Hold For Now at Barinthus Biotherapeutics plc (NASDAQ:BRNS)

Simply Wall St.

6 months ago

Increases to CEO Compensation Might Be Put On Hold For Now at Barinthus Biotherapeutics plc (NASDAQ:BRNS)

Barinthus Bio Names Experienced Physician, Leon Hooftman, M.D., as Chief Medical Officer

GlobeNewswire

7 months ago

Barinthus Bio Names Experienced Physician, Leon Hooftman, M.D., as Chief Medical Officer

Barinthus Bio Announces Topline Data from Phase 1b/2 APOLLO Trial of VTP-200 in Persistent High-Risk Human Papillomavirus (HPV) Infections

GlobeNewswire

7 months ago

Barinthus Bio Announces Topline Data from Phase 1b/2 APOLLO Trial of VTP-200 in Persistent High-Risk Human Papillomavirus (HPV) Infections

Barinthus Bio Reports Full Year 2023 Financial Results and Update on Corporate Developments

GlobeNewswire

8 months ago

Barinthus Bio Reports Full Year 2023 Financial Results and Update on Corporate Developments

How Much Upside is Left in Inovio (INO)? Wall Street Analysts Think 223.72%

Zacks

10 months ago

How Much Upside is Left in Inovio (INO)? Wall Street Analysts Think 223.72%

High Tide To Open First Canna Cabana Store in Fort McMurray, Alberta

PR Newswire

10 months ago

High Tide To Open First Canna Cabana Store in Fort McMurray, Alberta

USCB Financial Holdings Inc Reports Mixed Results Amid Economic Headwinds

GuruFocus.com

10 months ago

USCB Financial Holdings Inc Reports Mixed Results Amid Economic Headwinds

Hepsiburada Announces Changes to its Board of Directors

GlobeNewswire

10 months ago

Hepsiburada Announces Changes to its Board of Directors

Zacks.com featured highlights Otter Tail, OraSure, BioMarin and Regeneron

Zacks

10 months ago

Zacks.com featured highlights Otter Tail, OraSure, BioMarin and Regeneron

VIZSLA SILVER TO SPIN OUT NET SMELTER ROYALTY TO SHAREHOLDERS

CNW Group

10 months ago

VIZSLA SILVER TO SPIN OUT NET SMELTER ROYALTY TO SHAREHOLDERS

IperionX Letter to Shareholders

Business Wire

10 months ago

IperionX Letter to Shareholders

Is Erasca (NASDAQ:ERAS) In A Good Position To Invest In Growth?

Simply Wall St.

10 months ago

Is Erasca (NASDAQ:ERAS) In A Good Position To Invest In Growth?

Kopin Receives $20.5 Million Contract for New Thermal Weapon Sight Configuration

Business Wire

10 months ago

Kopin Receives $20.5 Million Contract for New Thermal Weapon Sight Configuration

Investing.com

10 months ago

Shoe retailer Genesco cuts full-year earnings forecast, shares plunge premarket

Here’s Why Cove Street Capital Reduced its Position in Lifecore Biomedical (LFCR)

Insider Monkey

10 months ago

Here’s Why Cove Street Capital Reduced its Position in Lifecore Biomedical (LFCR)

Shuffle Board: Gozen Taps Orta Exec, Genesco Names Journeys EVP

Sourcing Journal

10 months ago

Shuffle Board: Gozen Taps Orta Exec, Genesco Names Journeys EVP

Barinthus Bio Provides a Financial Update and Announces Anticipated 2024 Corporate Milestones

GlobeNewswire

10 months ago

Barinthus Bio Provides a Financial Update and Announces Anticipated 2024 Corporate Milestones

Molecular Partners and Orano Med Announce Co-Development Agreement for Radio-DARPin Therapies

GlobeNewswire

10 months ago

Molecular Partners and Orano Med Announce Co-Development Agreement for Radio-DARPin Therapies

Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements

GlobeNewswire

10 months ago

Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements

Kopin Corporation and MICLEDI Microdisplays Announce Agreement to Collaborate on microLED Displays for Next Generation Vision Solutions

Business Wire

10 months ago

Kopin Corporation and MICLEDI Microdisplays Announce Agreement to Collaborate on microLED Displays for Next Generation Vision Solutions

New partnership aims to advance vaccine against MERS coronavirus

GlobeNewswire

a year ago

New partnership aims to advance vaccine against MERS coronavirus

The Central and Eastern Europe Fund, Inc., The European Equity Fund, Inc., and The New Germany Fund, Inc. Make Yearly Distribution Announcements

Business Wire

a year ago

The Central and Eastern Europe Fund, Inc., The European Equity Fund, Inc., and The New Germany Fund, Inc. Make Yearly Distribution Announcements

12 Most Promising Cancer Stocks According to Analysts

Insider Monkey

a year ago

12 Most Promising Cancer Stocks According to Analysts

There's Reason For Concern Over Ardelyx, Inc.'s (NASDAQ:ARDX) Massive 36% Price Jump

Simply Wall St.

a year ago

There's Reason For Concern Over Ardelyx, Inc.'s (NASDAQ:ARDX) Massive 36% Price Jump

Co-Founder of Cibus Picks Up 23% More Stock

Simply Wall St.

a year ago

Co-Founder of Cibus Picks Up 23% More Stock

Cibus Announces $20.3 Million Registered Direct Offering

GlobeNewswire

a year ago

Cibus Announces $20.3 Million Registered Direct Offering

Erasca Granted FDA Fast Track Designation for Pan-RAF Inhibitor Naporafenib in Patients with Advanced NRAS-Mutated Melanoma

GlobeNewswire

a year ago

Erasca Granted FDA Fast Track Designation for Pan-RAF Inhibitor Naporafenib in Patients with Advanced NRAS-Mutated Melanoma

Insider Sell Alert: Third Harmonic Bio Inc's Julie Person Divests 12,863 Shares

GuruFocus.com

a year ago

Insider Sell Alert: Third Harmonic Bio Inc's Julie Person Divests 12,863 Shares

Presenting on the Emerging Growth Conference 65 Day 2 on December 7th Register Now

GlobeNewswire

a year ago

Presenting on the Emerging Growth Conference 65 Day 2 on December 7th Register Now

Analysts Expect Breakeven For nCino, Inc. (NASDAQ:NCNO) Before Long

Simply Wall St.

a year ago

Analysts Expect Breakeven For nCino, Inc. (NASDAQ:NCNO) Before Long

GlobeNewswire

a year ago

Kandi Technologies Announces Share Buyback of Up to $30 Million

Individual investors account for 39% of enGene Holdings Inc.'s (NASDAQ:ENGN) ownership, while private equity firms account for 37%

Simply Wall St.

a year ago

Individual investors account for 39% of enGene Holdings Inc.'s (NASDAQ:ENGN) ownership, while private equity firms account for 37%

Declining Stock and Decent Financials: Is The Market Wrong About Tactile Systems Technology, Inc. (NASDAQ:TCMD)?

Simply Wall St.

a year ago

Declining Stock and Decent Financials: Is The Market Wrong About Tactile Systems Technology, Inc. (NASDAQ:TCMD)?

Kandi’s First 500 Fully Electric Mini Golf Carts to Launch in US Market

GlobeNewswire

a year ago

Kandi’s First 500 Fully Electric Mini Golf Carts to Launch in US Market

Live Oak Bancshares Announces Executive Appointments, Including Walter J. Phifer Named as Chief Financial Officer

GlobeNewswire

a year ago

Live Oak Bancshares Announces Executive Appointments, Including Walter J. Phifer Named as Chief Financial Officer

GlobeNewswire

a year ago

Kandi America Partners with Peavey Mart to Expand Kandi Products into Canada

Barinthus Bio Presents Interim Data from Phase 2b HBV003 Trial and Phase 2a AB-729-202 Trial in Collaboration with Arbutus Biopharma in Chronic HBV Patients at AASLD

GlobeNewswire

a year ago

Barinthus Bio Presents Interim Data from Phase 2b HBV003 Trial and Phase 2a AB-729-202 Trial in Collaboration with Arbutus Biopharma in Chronic HBV Patients at AASLD

Arbutus Biopharma and Barinthus Bio Present Preliminary Data from Phase 2a Clinical Trial Combining Imdusiran with VTP-300 at AASLD - The Liver Meeting®

GlobeNewswire

a year ago

Arbutus Biopharma and Barinthus Bio Present Preliminary Data from Phase 2a Clinical Trial Combining Imdusiran with VTP-300 at AASLD - The Liver Meeting®

Barinthus Bio Reports Third Quarter 2023 Financial Results and Recent Corporate Developments

GlobeNewswire

a year ago

Barinthus Bio Reports Third Quarter 2023 Financial Results and Recent Corporate Developments

Kandi Technologies Group, Inc. (NASDAQ:KNDI) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Kandi Technologies Group, Inc. (NASDAQ:KNDI) Q3 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

a year ago

Q3 2023 Latham Group Inc Earnings Call

GuruFocus.com

a year ago

Latham Group Inc (SWIM) Reports 15.1% Decrease in Q3 Net Sales, Adjusted EBITDA Margin Improves

Associated Press Finance

a year ago

Latham Group: Q3 Earnings Snapshot

Lyra Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire

a year ago

Lyra Therapeutics to Participate in Upcoming Investor Conferences

Twin Disc, Incorporated (NASDAQ:TWIN) Q1 2024 Earnings Call Transcript

Insider Monkey

a year ago

Twin Disc, Incorporated (NASDAQ:TWIN) Q1 2024 Earnings Call Transcript

Late-Breaking Phase 1 Liver Metastasis Data from TriSalus Presented at SITC 2023 Supports Development of Innovative Immuno-oncology Approach for Liver and Pancreas Indications

Business Wire

a year ago

Late-Breaking Phase 1 Liver Metastasis Data from TriSalus Presented at SITC 2023 Supports Development of Innovative Immuno-oncology Approach for Liver and Pancreas Indications

Share on Social Networks: